Literature DB >> 5780202

Factor XIII in human plasma and platelets.

J McDonagh, R P McDonagh, J M Delâge, R H Wagner.   

Abstract

Plasma and platelet factor XIII levels were measured in normal human donors and in a patient congenitally deficient in factor XIII. The purpose of these experiments was to study the role of platelet factor XIII in blood coagulation. On polyacrylamide disc electrophoresis, factor XIII activity in extracts of washed normal platelets appeared as a single peak. This peak was missing or very low when factor XIII-deficient platelet extract was used. The patient was also studied before and after transfusion of fresh frozen plasma. Before transfusion, factor XIII activity could not be detected in the patient's plasma or platelet extracts. 24 hr after transfusion the plasma factor XIII level was still at the anticipated value, but factor XIII activity could not be detected in the platelet extracts. These experiments imply that plasma factor XIII was not transported across the platelet membrane in measurable quantities in vivo. This suggests that platelet factor XIII is a true platelet component and originates in the platelet precursor, the megakaryocyte. Thrombelastographic studies suggest that platelet factor XIII participates in the coagulation process. Thrombelastograms of factor XIII-deficient samples had decreased maximum amplitude and clot elasticity values. The abnormalities were fully corrected by the addition of washed normal platelets to factor XIII-deficient plasma; preincubation of the normal platelets in the deficient plasma had no additional effect. This indicates that platelet factor XIII is immediately available during clot formation.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5780202      PMCID: PMC322303          DOI: 10.1172/JCI106053

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Effects of human plasma on thrombelastographic patterns produced by fibrinolytic agents in fibrin clots.

Authors:  K Egeblad; T Astrup
Journal:  Br J Haematol       Date:  1967-01       Impact factor: 6.998

2.  A simple method for preparing fibrinogen.

Authors:  W Straughn; R H Wagner
Journal:  Thromb Diath Haemorrh       Date:  1966-07-31

3.  Platelet and plasma Factor 13 (fibrin-stabilizing factor).

Authors:  T H Kiesselbach; R H Wagner
Journal:  Thromb Diath Haemorrh Suppl       Date:  1967

4.  Fibrin-stabilizing factor: a thrombin-labile platelet protein.

Authors:  T H Kiesselbach; R H Wagner
Journal:  Am J Physiol       Date:  1966-12

5.  The transpeptidase system which crosslinks fibrin by gamma-glutamyle-episilon-lysine bonds.

Authors:  L Lorand; J Downey; T Gotoh; A Jacobsen; S Tokura
Journal:  Biochem Biophys Res Commun       Date:  1968-04-19       Impact factor: 3.575

6.  The identification of isopeptide crosslinks in insoluble fibrin.

Authors:  S Matacić; A G Loewy
Journal:  Biochem Biophys Res Commun       Date:  1968-02-26       Impact factor: 3.575

7.  [The practical performance of blood platelet transfusion].

Authors:  U Bucher; H Kummer
Journal:  Schweiz Med Wochenschr       Date:  1968-10-19

8.  Fibrinase deficiency.

Authors:  S Fisher
Journal:  Isr J Med Sci       Date:  1965-07

9.  Congenital deficiency of factor 13 (fibrin-stabilizing factor): Report of a case and review of the literature.

Authors:  A F Britten
Journal:  Am J Med       Date:  1967-11       Impact factor: 4.965

10.  [Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine].

Authors:  J J Pisano; J S Finlayson; M P Peyton
Journal:  Science       Date:  1968-05-24       Impact factor: 47.728

View more
  15 in total

Review 1.  The human fibrin-stabilizing factors.

Authors:  H Bohn
Journal:  Mol Cell Biochem       Date:  1978-06-28       Impact factor: 3.396

2.  Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII.

Authors:  C W Francis; V J Marder
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

3.  Calcium-induced dissociation of human plasma factor XIII and the appearance of catalytic activity.

Authors:  R D Cooke
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

4.  [Studies on plasma factor XIII-activity in acute leukaemia].

Authors:  H Rasche; M Dietrich; V Hiemeyer
Journal:  Klin Wochenschr       Date:  1972-11-01

5.  [Simplified radiologic factor XIII determination and its clinical use in congenital factor XIII deficiency (I)].

Authors:  R Egbring; W Schmidt; K Havemann
Journal:  Blut       Date:  1973-07

Review 6.  [Blood coagulation factor XIII and fibrin stabilization (author's transl)].

Authors:  H Rasche
Journal:  Klin Wochenschr       Date:  1975-12-15

7.  The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.

Authors:  Yacine Boulaftali; Lamia Lamrani; Marie-Catherine Rouzaud; Stéphane Loyau; Martine Jandrot-Perrus; Marie-Christine Bouton; Benoît Ho-Tin-Noé
Journal:  Thromb Haemost       Date:  2012-03-08       Impact factor: 5.249

8.  [Longtime therapy of congenital factor XIII deficiency using factor XIII concentrate].

Authors:  R Egbring; K Andrassy; K Havemann; G Fuchs; B Ruf; K Schander; H Trobisch
Journal:  Blut       Date:  1976-12

9.  Immunological studies of coagulation factor XIII.

Authors:  E D Israels; F Paraskevas; L G Israels
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

10.  Coagulation factors and proteinase inhibitors in the plasma of children with acute lymphoblastic leukoses. Behaviour before and during treatment according to Protocol I of the Cooperative Leukaemia Study COALL-80.

Authors:  M Reitz; G Witzke; R Egbring; P Gutjahr
Journal:  Klin Wochenschr       Date:  1984-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.